Cytokinetics Share Holder Equity 2010-2024 | CYTK

Cytokinetics share holder equity for the quarter ending September 30, 2024 was $-0.014B, a 96.83% decline year-over-year.

  • Cytokinetics share holder equity for 2023 was $-0.386B, a 258.04% increase from 2022.
  • Cytokinetics share holder equity for 2022 was $-0.108B, a 144.25% decline from 2021.
  • Cytokinetics share holder equity for 2021 was $0.244B, a 115.08% increase from 2020.

Cytokinetics Share Holder Equity 2010-2024 | CYTK

  • Cytokinetics share holder equity for 2023 was $-0.386B, a 258.04% increase from 2022.
  • Cytokinetics share holder equity for 2022 was $-0.108B, a 144.25% decline from 2021.
  • Cytokinetics share holder equity for 2021 was $0.244B, a 115.08% increase from 2020.